Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-12-000011)

Filing Details

Accession Number:: 0000711377-12-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-10 11:38:30
Reporting Period:: 2012-08-08

Filing Date:: 2012-08-10
Accepted Time:: 2012-08-10 11:38:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1188987	A Terri Morrical		Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-08-08	2,551	$13.55	18,239	No	4	M	Direct
Common Stock	Disposition	2012-08-08	2,551	$39.97	15,688	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock (Right-to-Buy)	Disposition	2012-08-08	2,551	$0.00	2,551	$13.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
65,691		2012-08-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	18,788	Indirect	See Footnote

Footnotes

Options were granted 8/9/2007, vest 20% annually each year for five years, and expire on 8/9/2012
Shares are held in the Neogen 401(k) Plan